Literatura académica sobre el tema "Infections à Acinetobacter – Chimiothérapie"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Infections à Acinetobacter – Chimiothérapie".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Infections à Acinetobacter – Chimiothérapie"
Wilson, Brigid M., Federico Perez, Qing Pan, Yunyun Jiang, Scott R. Evans y Robert A. Bonomo. "Acinetobacter Infections". Clinical Infectious Diseases 71, n.º 5 (17 de noviembre de 2019): 1357–58. http://dx.doi.org/10.1093/cid/ciz1099.
Texto completoSnoeck, R. y E. De Clercq. "La chimiothérapie des infections a cytomégalovirus". Médecine et Maladies Infectieuses 18 (marzo de 1988): 79–84. http://dx.doi.org/10.1016/s0399-077x(88)80102-1.
Texto completoÖzgür, Özlem y Necmi Aksaray. "Acinetobacter Infections and Treatment". Journal of Pediatric Infection 8, n.º 1 (17 de marzo de 2014): 28–32. http://dx.doi.org/10.5152/ced.2013.38.
Texto completoJoly-Guillou, M. L. "Acinetobacter et infections nosocomiales". Revue Française des Laboratoires 2002, n.º 345 (septiembre de 2002): 14. http://dx.doi.org/10.1016/s0338-9898(02)80247-5.
Texto completoFalagas, M. E., E. A. Karveli, I. Kelesidis y T. Kelesidis. "Community-acquired Acinetobacter infections". European Journal of Clinical Microbiology & Infectious Diseases 26, n.º 12 (16 de agosto de 2007): 857–68. http://dx.doi.org/10.1007/s10096-007-0365-6.
Texto completoGarnacho-Montero, José y Jean-François Timsit. "Managing Acinetobacter baumannii infections". Current Opinion in Infectious Diseases 32, n.º 1 (febrero de 2019): 69–76. http://dx.doi.org/10.1097/qco.0000000000000518.
Texto completoBergogne-Bérézin, E. "Treatment of Acinetobacter infections". Expert Opinion on Investigational Drugs 6, n.º 2 (febrero de 1997): 119–27. http://dx.doi.org/10.1517/13543784.6.2.119.
Texto completoMiah, Md Ruhul Amin. "Acinetobacter baumannii Hospital Acquired Infections." Bangladesh Journal of Medical Microbiology 13, n.º 1 (10 de enero de 2019): 1–3. http://dx.doi.org/10.3329/bjmm.v13i1.51778.
Texto completoFleming, Irma D., Monika A. Krezalek, Natalia Belogortseva, Alexander Zaborin, Jennifer Defazio, Laxmipradha Chandrasekar, Luis A. Actis, Olga Zaborina y John C. Alverdy. "Modeling Acinetobacter baumannii wound infections". Journal of Trauma and Acute Care Surgery 82, n.º 3 (marzo de 2017): 557–65. http://dx.doi.org/10.1097/ta.0000000000001338.
Texto completoLevin, Anna S. "Treatment of Acinetobacter spp. infections". Expert Opinion on Pharmacotherapy 4, n.º 8 (agosto de 2003): 1289–96. http://dx.doi.org/10.1517/14656566.4.8.1289.
Texto completoTesis sobre el tema "Infections à Acinetobacter – Chimiothérapie"
Antraygues, Kévin. "Conception, synthèse et évaluation biologique de nouveaux ansamacrolides dans le traitement d'infections bactériennes". Electronic Thesis or Diss., Université de Lille (2022-....), 2022. http://www.theses.fr/2022ULILS027.
Texto completoAntimicrobial resistance is a major public health issue nowadays and this will be even more true in the coming decades. Among the bacteria involved in this alarming phenomenon, Acinetobacter baumannii and Mycobacterium abscessus are both resistant to many antibiotics currently available on the market. Research and development of new antibiotics is therefore necessary to fight these pathogens.Rifabutin, a semi-synthetic macrocyle of the rifamycin class, has recently shown interesting in vitro activities against A. baumannii and M. abscessus, which then translated into in vivo efficacy. Rifabutin therefore seems to be promising to the fight against these bacteria, but the use of this antibiotic is currently limited. In order to treat an infection caused by A. baumannii, rifabutin requires to be injected by intravenous route, which is not so easy because of the low water solubility of the molecule. Concerning the treatment of M. abscessus infections, rifabutin, although effective in vivo, has moderate activity against this mycobacterium, which could lead to therapeutic escape.Therefore, the work presented in this thesis manuscript seeks to address the limitations of rifabutin mentioned above.In a first part, water-soluble prodrugs of rifabutin have been synthesized in order to allow an intravenous injection and thus fight effectively against A. baumannii infections. To achieve the release of rifabutin after enzymatic cleavage in plasma, an intramolecular cyclization strategy was employed. After evaluation of the compounds in plasma stability assays, structure-stability relationship studies were performed, leading to the identification of three promising prodrugs. Additional in vitro studies were then conducted such as the measurement of aqueous solubility and bacterial growth inhibition, and finally an in vivo pharmacokinetic study was performed to be able to select for a preclinical candidate.In a second part, analogues of rifabutin modified at the C25 position were synthesized to identify more potent compounds. Based on a parallel chemistry strategy, a large number of derivatives were rapidly obtained and then evaluated against M. abscessus in order to conduct structure-activity relationship studies
Henein, Alexandra Elisabeth. "The potential of bacteriophage therapy in Acinetobacter spp. infections". Thesis, University of Brighton, 2009. https://research.brighton.ac.uk/en/studentTheses/9726f331-e5dc-4b67-a282-44cac1fe978f.
Texto completoDiallo, Bruno Salla. "Études des acinetobacter : à propos de 98 souches isolées en milieu hospitalier". Bordeaux 2, 1990. http://www.theses.fr/1990BOR23091.
Texto completoGagné, Stéphanie. "Étude des mécanismes de virulence du pathogène nosocomial Acinetobacter baumannii". Thesis, Lyon, 2018. http://www.theses.fr/2018LYSE1045/document.
Texto completoA. baumannii is an hospital acquired pathogen which causes mainly ventilator associated infection, urinary tract infection and bacteraemia. Last years Multi Drug Resistant strains increase and nosocomial infection cause by A. baumannii also which led him as a serious health care problem. We compare different strains in propose to find phenotype that can explain hypervirulent strain emergence. We studied type six secretion and showed that the complexity of A. baumannii virulence mechanism. Indeed type six secretion system regulation is strain dependant. Secondary we study hypervirulent strain and showed that intracellular stage exists and there is intracellular replication. Also hypervirulent strain induces less immune response. Those two mechanisms can explain A. baumannii hypervirulent phenotype
Fabre, David. "Approche pharmacocinétique de l'antibiothérapie dans les infections pulmonaires". Montpellier 1, 1995. http://www.theses.fr/1995MON13504.
Texto completoHauret, Sylvie. "Epidémiologie moléculaire d'infections nosocomiales à Acinetobacter Baumannii dans un service de réanimation". Bordeaux 2, 1996. http://www.theses.fr/1996BOR2P039.
Texto completoWebster, Carol Ann. "The use of molecular typing systems for studying the epidemiology of Acinetobacter infections". Thesis, University of Nottingham, 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.388315.
Texto completoChou, So-ha y 周素霞. "Molecular epidemiology of carbapenem-resistant acinetobacter baumanniiin patients and their surrounding environment". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2012. http://hub.hku.hk/bib/B48333669.
Texto completopublished_or_final_version
Microbiology
Master
Master of Medical Sciences
Brandely, Marie-Laure. "Nouvelles prises en charge des principales infections fongiques hospitalières : évaluation pharmaco-économique". Paris 5, 1999. http://www.theses.fr/1999PA05P183.
Texto completoAdegoke, Anthony Ayodeji. "Commensal bacteria belonging to the Staphylococcus Acinetobacter and Stenotrophomonas genera as reservoirs of antibiotic resistance determinants in the environment of Nkonkobe Municipality, Eastern Cape Province , South Africa". Thesis, University of Fort Hare, 2012. http://hdl.handle.net/10353/6539.
Texto completoLibros sobre el tema "Infections à Acinetobacter – Chimiothérapie"
E, Bergogne-Bérézin, Joly-Guillou M. L y Towner K. J, eds. Acinetobacter: Microbiology, epidemiology, infections, management. Boca Raton: CRC Press, 1996.
Buscar texto completoE, Bergogne-Bérézin, Friedman Herman 1931-2007 y Bendinelli Mauro, eds. Acinetobacter biology and pathogenesis. New York: Springer, 2008.
Buscar texto completoE, Bergogne-Bérézin, Friedman Herman 1931-2007 y Bendinelli Mauro, eds. Acinetobacter biology and pathogenesis. New York: Springer, 2008.
Buscar texto completoUlrike, Gerischer, ed. Acinetobacter molecular biology. [Wymondham?]: Caister Academic Press, 2008.
Buscar texto completoJacques, Thèze y Debré Patrice, eds. Le sida à l'ère des multithérapies. Paris: Elsevier, 2000.
Buscar texto completoDariosecq, Jean-Michel. Infection VIH: Mémento thérapeutique 2003. 6a ed. Rueil-Malmaison: Doin, 2003.
Buscar texto completoBattling HIV/AIDS: A decision maker's guide to the procurement of medicines and related supplies. Washington, DC: World Bank, 2004.
Buscar texto completoP, Sawan Samuel y Manivannan Gurusamy 1960-, eds. Antimicrobial/anti-infective materials: Principles, applications and devices. Lancaster, Pa: Technomic Pub. Co., 2000.
Buscar texto completoFriedman, Herman, Mauro Bendinelli y Eugénie Bergogne-Bérézin. Acinetobacter: Biology and Pathogenesis. Springer, 2010.
Buscar texto completoBergogne-Berezin, E., Marie-Laure Joly-Guillou y Kevin J. Towner. Acinetobacter: Microbiology, Epidemiology, Infections, Management. Taylor & Francis Group, 2020.
Buscar texto completoCapítulos de libros sobre el tema "Infections à Acinetobacter – Chimiothérapie"
Champion, Howard R., Nova L. Panebianco, Jan J. De Waele, Lewis J. Kaplan, Manu L. N. G. Malbrain, Annie L. Slaughter, Walter L. Biffl et al. "Acinetobacter Infections". En Encyclopedia of Intensive Care Medicine, 41–47. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-00418-6_3.
Texto completoDijkshoorn, Lenie. "Acinetobacter baumannii". En Molecular Typing in Bacterial Infections, 433–56. Totowa, NJ: Humana Press, 2012. http://dx.doi.org/10.1007/978-1-62703-185-1_25.
Texto completoNurjadi, Dennis y Sébastien Boutin. "Acinetobacter baumannii". En Molecular Typing in Bacterial Infections, Volume II, 113–29. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-83217-9_6.
Texto completoJoly-Guillou, M. L. "Nosocomial and Community-acquired Acinetobacter Infections". En Acinetobacter Biology and Pathogenesis, 155–65. New York, NY: Springer US, 2008. http://dx.doi.org/10.1007/978-0-387-77944-7_9.
Texto completoBaneman, Emily y Meenakshi M. Rana. "Management of Acinetobacter Infections in the Immunosuppressed Host". En Emerging Transplant Infections, 1–19. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-01751-4_21-1.
Texto completoBaneman, Emily y Meenakshi M. Rana. "Management of Acinetobacter Infections in the Immunosuppressed Host". En Emerging Transplant Infections, 371–89. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-25869-6_21.
Texto completoRajkumari, Jobina y Busi Siddhardha. "Acinetobacter baumannii: Infections and Drug Resistance". En Model Organisms for Microbial Pathogenesis, Biofilm Formation and Antimicrobial Drug Discovery, 257–71. Singapore: Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-1695-5_14.
Texto completoRubinstein, E. y I. Levi. "Acinetobacter Infections in Intensive Care Units". En Yearbook of Intensive Care and Emergency Medicine, 542–51. Berlin, Heidelberg: Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-642-80053-5_44.
Texto completoJoly-Guillou, M. L., E. Bergogne-Bérézin y J. F. Vieu. "Epidemiology of Acinetobacter Strains Isolated from Nosocomial Infections in France". En The Biology of Acinetobacter, 63–68. Boston, MA: Springer US, 1991. http://dx.doi.org/10.1007/978-1-4899-3553-3_5.
Texto completoVergidis, Paschalis y Matthew E. Falagas. "Control of Multi-Drug Resistant Acinetobacter Infections". En Antibiotic Policies, 117–25. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4419-1734-8_10.
Texto completoActas de conferencias sobre el tema "Infections à Acinetobacter – Chimiothérapie"
K. Alkhudhairy, Miaad y Elhassan Benyagoub. "Frequency of Genes Mediated β-lactams Resistance in Acinetobacter Baumannii Isolates from Iraq". En X INTERNATIONAL CONGRESS OF PURE AND APPLIED TECHNOLOGICAL SCIENCES. Rimar Academy, 2023. http://dx.doi.org/10.47832/minarcongress10-2.
Texto completoAl-Ghanimi, Ali Abdul Kadhim y Amaal Sahib Al-Zughaibi. "Molecular Identification of Acinetobacter baumannii and Staphylococcus aureus isolated from wound infections in Karbala governorate Iraq". En THE 9TH INTERNATIONAL CONFERENCE ON APPLIED SCIENCE AND TECHNOLOGY (ICAST 2021). AIP Publishing, 2022. http://dx.doi.org/10.1063/5.0113631.
Texto completoVrancianu, Corneliu Ovidiu, Roxana-Elena Cristian, Elena-Georgiana Dobre, Catalina Zenoaga-Barbarosie, Ecaterina-Teodora Chirea, Ioana Crunteanu y Mihai-Viorel Dionisie. "The Impact of Acinetobacter baumannii Infections in COVID-19 Patients Admitted in Hospital Intensive Care Units". En ECM 2023. Basel Switzerland: MDPI, 2023. http://dx.doi.org/10.3390/ecm2023-16479.
Texto completoGrosse-Onnebrink, Joerg, Heymut Omran, Johanna Rudloff y Claudius Werner. "Acinetobacter baumanii and Stenotrophomonas maltophilia are associated with lower airway infections in tracheostomised children and young adults". En ERS International Congress 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/1393003.congress-2017.pa4137.
Texto completoHodyna, Diana. "LONG-CHAIN TRIPHENYLPHOSPHONIUM IONIC LIQUIDS AS ANTIBACTERIALS IN POTENTIAL POLYMICROBIAL INFECTIONS CAUSED BY STAPHYLOCOCCUS AUREUS AND ACINETOBACTER BAUMANNII STRAINS". En THEORETICAL AND PRACTICAL ASPECTS OF MODERN SCIENTIFIC RESEARCH, Chair Ivan Semenyuta, Sergiy Rogalsky y Larysa Metelytsia. European Scientific Platform, 2023. http://dx.doi.org/10.36074/logos-28.04.2023.26.
Texto completoMisri, A. R. "To Study the Epidemiology of Multidrug Resistant Acinetobacter Infections Among Critically Ill Adult Patients Admitted in Medical Intensive Care Unit". En American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a6508.
Texto completoInformes sobre el tema "Infections à Acinetobacter – Chimiothérapie"
Meddaugh, Paul y Uzo Chukwuma. Acinetobacter Species Infections Among Navy and Marine Corps Beneficiaries: 2013 Annual Report. Fort Belvoir, VA: Defense Technical Information Center, noviembre de 2014. http://dx.doi.org/10.21236/ada611595.
Texto completoMeddaugh, Paul y Uzo Chukwuma. Acinetobacter Species Infections among Navy and Marine Corps Beneficiaries: 2014 Annual Report. Fort Belvoir, VA: Defense Technical Information Center, julio de 2015. http://dx.doi.org/10.21236/ada621496.
Texto completoMaraolo, Alberto Enrico y David SY Ong. Colistin plus meropenem versus colistin alone for invasive infections caused by Carbapenem-Resistant Acinetobacter baumannii: a rapid systematic review of randomized controlled trials using Bayesian meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, enero de 2023. http://dx.doi.org/10.37766/inplasy2023.1.0055.
Texto completo